Filing Details

Accession Number:
0001179110-13-010170
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-11 21:04:34
Reporting Period:
2013-06-07
Filing Date:
2013-06-11
Accepted Time:
2013-06-11 21:04:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225509 M Suzanne Shema C/O Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco CA 94080
Evp, Gc And Corp. Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-07 1,214 $32.07 35,832 No 4 M Direct
Common Stock Acquisiton 2013-06-07 656 $30.28 36,488 No 4 M Direct
Common Stock Acquisiton 2013-06-07 802 $35.18 37,290 No 4 M Direct
Common Stock Acquisiton 2013-06-07 584 $37.68 37,874 No 4 M Direct
Common Stock Acquisiton 2013-06-07 796 $37.68 38,670 No 4 M Direct
Common Stock Disposition 2013-06-07 2,952 $90.91 35,718 No 4 S Direct
Common Stock Disposition 2013-06-07 1,100 $92.06 34,618 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-06-07 1,214 $0.00 1,214 $32.07
Common Stock Stock Option (Right to Buy) Disposition 2013-06-07 656 $0.00 656 $30.28
Common Stock Common Stock Disposition 2013-06-07 802 $0.00 802 $35.18
Common Stock Stock Option (Right to Buy) Disposition 2013-06-07 584 $0.00 584 $37.68
Common Stock Stock Option (Right to Buy) Disposition 2013-06-07 796 $0.00 796 $37.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,115 2019-08-31 No 4 M Direct
6,563 2020-03-31 No 4 M Direct
17,646 2021-03-31 No 4 M Direct
19,833 2022-03-29 No 4 M Direct
27,058 2022-03-29 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices ranging from $90.8001 to $91.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices ranging from $92.02 to $92.1001. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Twenty-Five percent of the shares subject to the option vest and become exercisable one year from the date of grant and vest and beceome exercisable at a rate of 1/48th per month thereafter.
  5. 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
  6. The shares shall vest monthly from the date of grant at a rate of 1/48th per month over a period of 48 months.